Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Am J Prev Med. 2023 Jan 28;65(1):39–44. doi: 10.1016/j.amepre.2023.01.006

Table 1.

Cost per participant, intervention effectiveness, and cost per quit based on dedicated, supervised staff.

Treatment Cost/Participant (95% CI) % Reduced (95% CI) Cost/Quit Beyond Usual Care (95% CI)
Study 1

BNI+NRt+QL+booster $860 ($825 - $953) 7.3% (3.3%-11.5%) $11,814 ($7,521 - $25,349)

Study 2

Cost/BNI quit $372 ($364 - $379) 4.5% (0.8%, 8.3%) $8,184 ($4,255, $36,388)
Cost/NRT quit $593 ($583 - $603) 6.4% (2.7%, 10.2%) $9,209 ($5,782, $22,250)
Cost/Quitline quit $284 ($268 - $381) 2.3% (−1.5%, 6.1%) $12,496 ($4,522, infinity)
Cost/Textline quit $337 ($335 - $340) 0.8% (−3.0%, 4.6%) $44,484 ($7,292, infinity)
Add NRT to BNI $374 ($364 - $384) 6.4% (2.7%, 10.2%) $5,808 ($3,656, $14,146)
Add QL to BNI + NRT $63 ($46 - $160) 2.3% (−1.5%, 6.1%) $2,760 ($820, infinity)
BNI & NRT combined $746 ($729 - $763) 11.0% (6.0%, 16.0%) $6,791 ($4,564, $13,259)
BNI, NRT & QL combined $808 (775 - $813) 13.3% (7.6%, 18.9%) $6,100 ($4,043, $12,274)